They also discovered amplifications in the well-known checkpoint controlling immune targets programmed death ligand 1 (PD-L1, CD274) and PD-L2 (PDCD1LG2) in the keratin-low and -high squamous cancers, but not in the adenocarcinoma enriched group. This evidence concerns the gene CD274 and adenocarcinoma.